Earnings History Data for Catalyst Pharmaceuticals, Inc. (CPRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2022 AH 4:10 PM ET
(Aug 9)
CPRX Catalyst Pharmaceuticals, Inc. 981.55 0.20 0.17 0.14 Catalyst Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.11, revenue of $53.11M beats by $4.03M, re-affirms FY22 guidance
[8/9/2022 4:31 PM]
13.15 2.55 
(24.06%)
11.95 1.35 
(12.74%)
4.81 - 13.24 3,696,430 1,770,000 22,103
10-05-2022 AH 4:20 PM ET
(May 10)
CPRX Catalyst Pharmaceuticals, Inc. 742.07 0.12 0.14 0.09 Catalyst Pharmaceuticals Non-GAAP EPS of $0.18, revenue of $43.09M
[5/10/2022 4:15 PM]
6.53 -0.40 
(-5.84%)
6.90 -0.03 
(-0.43%)
4.43 - 8.64 1,274,770 1,430,000 1,352
16-03-2022 AH 4:15 PM ET
(Mar 16)
CPRX Catalyst Pharmaceuticals, Inc. 786.79 0.09 0.12 0.11 Catalyst Pharmaceuticals GAAP EPS of $0.09 misses by $0.03, revenue of $38.31M beats by $0.13M
[3/16/2022 4:23 PM]
7.35 -0.54 
(-6.84%)
7.50 -0.39 
(-4.94%)
4.15 - 8.30 1,142,081 1,090,198 23,633
09-11-2021 AH 4:40 PM ET
(Nov 9)
CPRX Catalyst Pharmaceuticals, Inc. 644.80 0.10 0.10 0.11 Catalyst Pharmaceuticals EPS beats by $0.04, beats on revenue
[11/9/2021 4:35 PM]
6.46 0.29 
(4.70%)
6.27 0.10 
(1.62%)
3.22 - 6.66 1,076,859 710,000 4,707
09-08-2021 AH 5:30 PM ET
(Aug 9)
CPRX Catalyst Pharmaceuticals, Inc. 607.78 0.14 0.09 0.09 Catalyst Pharmaceuticals EPS beats by $0.01, beats on revenue
[8/9/2021 4:42 PM]
5.93 0.17 
(2.86%)
5.92 0.16 
(2.78%)
2.88 - 6.22 648,586 700,000 6,158
10-05-2021 AH 5:25 PM ET
(May 10)
CPRX Catalyst Pharmaceuticals, Inc. 484.86 0.09 0.09 0.10 Catalyst Pharmaceuticals EPS misses by $0.02, misses on revenue
[5/10/2021 5:34 PM]
4.73 -0.09 
(-1.87%)
4.61 -0.21 
(-4.36%)
2.88 - 5.19 1,215,296 1,280,000 18,392
15-03-2021 AH 5:20 PM ET
(Mar 15)
CPRX Catalyst Pharmaceuticals, Inc. 390.75 0.11 0.09 0.07 Catalyst Pharmaceuticals EPS beats by $0.02, beats on revenue
[3/15/2021 5:29 PM]
4.13 0.19 
(4.82%)
3.95 0.01 
(0.25%)
2.56 - 5.19 2,105,359 1,488,808 34,337
09-11-2020 AH 4:15 PM ET
(Nov 10)
CPRX Catalyst Pharmaceuticals, Inc. 344.53 0.11 0.09 0.13 Catalyst Pharmaceuticals EPS beats by $0.31, misses on revenue
[11/9/2020 5:24 PM]
3.39 0.08 
(2.42%)
3.42 0.11 
(3.32%)
2.55 - 5.28 1,733,537 1,358,702 3,939
10-08-2020 AH 4:15 PM ET
(Aug 10)
CPRX Catalyst Pharmaceuticals, Inc. 428.71 0.09 0.08 0.10 Catalyst Pharmaceuticals EPS in-line, beats on revenue
[8/10/2020 4:19 PM]
3.46 -0.81 
(-18.99%)
3.90 -0.36 
(-8.56%)
2.55 - 7.67 5,020,050 2,106,475 246,045